Numerof Consultant Christopher de Wolff led a session on Using RWE to Kickstart Innovation at the 2014 eyeforpharma Real World Evidence & Data Partnerships Summit on October 15.  Executives from Christiana Care Health System, National Health Council, and Actavis joined Christopher in examining how RWE can be used to improve understanding of treatment pathways; better target specific populations and unmet medical needs; shape hypotheses to test through research; and contribute to higher value products and faster, better decision making.

For more information about the conference and Christopher’s panel, click here.